CorConsult Rx: Evidence-Based Medicine and Pharmacy

On this episode, we review the pathophysiology and pharmacotherapy involved with the treatment of pulmonary arterial hypertension. If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

On this episode, we discuss the updated 2019 GINA (Asthma) guidelines. We review basic pathophysiology and diagnostics. We then examine the updated treatment options including the use of PRN inhaled ICS + formoterol in place of an albuterol inhaler. Below is a link to the GINA pocket guidelines: https://ginasthma.org/wp-content/uploads/2019/04/GINA-2019-main-Pocket-Guide-wms.pdf If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

On this episode, we review various disease states by going through a patient case. We talk about diabetes management, HFrEF, hypertension, dyslipidemia, ASCVD, osteoarthritis, neuropathy, depression, etc. The patient case will be available on our website under the "Show Notes" heading. Let us know if you would handle any of the disease states differently. Check out our podcast merchandise at https://corconsult-rx.myshopify.com If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

On this episode we give a brief overview of the management of both hepatitis A and B. We also review ACIP immunization recommendations for both diseases. This review only covers the surface of these disease and we greatly encourage you to read further on your own. Below is the link to the Infectious Disease Society of America guidelines: https://www.idsociety.org/globalassets/idsa/practice-guidelines/chronic_hep_b_update_2009-8_24_2009.pdf If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.  

This episode was originally supposed to be a simple topic discussion between my student and me. We ended up recording it as a podcast episode that will hopefully serve as a quick review of material that has been covered in other episodes. The patient case that we discussed during the episode: 63 y/o female with diabetes, HFrEF, hypertension. Medications: A1c = 8.9% HFrEF – EF = 30% BP = 154/84 mmHg Glargine-Lantus insulin 36 U QAM Pioglitazone 45 mg Lisinopril 10 mg HCTZ 25 mg QAM Metoprolol tartrate 50 mg BID Carvedilol 25mg BID Doxazosin 4 mg daily  èSTOP  Simvastatin 20 mg She presents for pharmacotherapy management   If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.  

On this episode, we give an overview of allergic rhinitis. We discuss some background information, pathophysiology, and non-pharmacological treatment options. Then we review all the different pharmacotherapy options currently available.  If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

On this episode, we are joined by MUSC College of Pharmacy P4 Ryan Rosenblatt. We discuss some pathophysiology and microbiology involved with urinary tract infections. We then review some of the pharmacotherapy options available for treatment.  If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

On this episode, we review ulcerative colitis. We compare and contrast the differences between ulcerative colitis and crohn's disease. We walk through most of the treatment options available as well as the updated 2019 guidelines.  The 2019 UC guidelines from the American College of Gastroenterology can be found at the following link: http://gi.org/clinical-guidelines/clinical-guidelines-sortable-list/?sort=datedesc If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

On this episode, we provide a very brief overview of hyperthyroidism. We discuss some of the causes as well as thyrotoxicosis and thyroid storm.  We kept this discussion simple and didn't go into much detail. We will provide a more extensive review in later episodes.   If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

On this episode, we are joined by Brian Gilbert, PharmD, BCPS, BCCCP, David Moran, PharmD, and Jacob Reeder, PharmD, BCCCP to discuss andexanet alfa (Andexxa). We contrast the DOAC benefits that are popular among the ambulatory care community with the DOAC risks that the critical care teams often deal with. Dr. Gilbert leads the review of some concerns that many clinicians have with Andexxa. We recently had a paper publish in the American Journal of Emergency Medicine (Dr. Gilbert was the lead author). The name of the article and link can be found below: Throwing it in reverse: An update on reversal of oral factor Xa inhibitors https://doi.org/10.1016/j.ajem.2019.04.007   If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.  

On this episode, we give an overview of glaucoma. We review some background information including the different classifications of glaucoma and pathophysiology. We then discuss the various classes of medications that are used to reduce and maintain intraocular pressure. If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.  

On this episode we review various tips and trips for successfully completing medication therapy management (MTM) encounters. We discuss the best ways for conducting complete medication reviews (CMRs).  We answer questions from pharmacists on Facebook as well as review various disease states.  If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

On this episode, we review the pathophysiology and pharmacotherapy of atopic dermatitis. We discuss different moisturizers and cleansers that patients can use to keep their skin healthy. We describe common topical corticosteroids used in atopic dermatitis as well as their potencies. We also go over some of the newer medications like crisaborole (Eucrisa) and dupilumab (Dupixent). We also list several new studies that have recently been published that examined treatment options such as melatonin, probiotics, and montelukast (Singulair). He are some of the new studies that we referenced: Patel KR, Immaneni S, Singam V, Rastogi S, Silverberg JI. Association between atopic dermatitis, depression, and suicidal ideation: A systematic review and meta-analysis.  J Am Acad Dermatol. 2019;80(2):402.  Taghavi Ardakani, et al.The effects of melatonin administration on disease severity and sleep quality in children with atopic dermatitis: A randomized, double-blinded, placebo-controlled trial. Pediatric Allergy Immunol. 2018;29(8):834. Makrgeorgou A, et al. Probiotics for treating eczema. Cochrane Database Syst Rev. 2018;11:CD006135. Ferguson L, et al. Leukotriene receptor antagonists for eczema. Cochrane Database Syst Rev. 2018;10:CD011224. If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.      

On this episode, we are joined by Jon Roth, MS, CAE. Mr. Roth is the current CEO of the California Pharmacists Association. CPhA is the largest statewide professional society of pharmacists in the country. Mr Roth has been involved in the health care sector for the last 25 years. He was also fundamental in getting the Senate Bill 493 passed which gave pharmacists in CA provider status.  Mr Roth also discussed CPhA's upcoming event Western Pharmacy Exchange (April 12-14, 2019). He was gracious enough to offer any CorConsult Rx listener a discounted rate to attend the conference. Contact CPhA's Vice President of Member Development, Sheila Johnston at (916)779-45-07. Let Miss Sheila know you are a CorConsult Rx listener and you'll save $150 on your admission cost! Make sure to follow @capharm on Instagram and Twitter. If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.    

On this episode, we discuss the recent Arizona House Bill 2548 that will allow pharmacists more prescribing authority. We also review RIPE therapy (rifampin, isoniazid, pyrazinamide, and ethambutol) as well as some other treatment options available for latent and active tuberculosis.  Go check out Rx Coffee for all your caffeine needs! https://drinkrxcoffee.com If you have any questions, reach out to us on any of the following: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.